The cancer-related clients, including mitogen-activated protein kinase (MAPK) kinase, extracellular signal-regulated kinase (Erk) 1/2, and Akt [49, 51], take part in the proliferation, invasion and resistance of cancer cells [49, 52, 53]. Here, AKT1 is linked to cancer.